SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA crypto token continues to face intense community backlash and skepticism, with investors frequently labeling it a "pump-and-dump" scam that has experienced a near-total loss of value since its launch. Discussion forums are dominated by users venting frustration over significant financial losses, questioning the legitimacy of the project's developers, and drawing parallels between this asset and other controversial Trump-family-backed ventures.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is seeing increased investor scrutiny as the market evaluates the airline's latest share buyback program and its ability to improve financial performance amid fluctuating fuel costs and competitive industry conditions. Community sentiment remains polarized, with some traders optimistic about long-term potential following recent NCIB authorization, while others express frustration over extended periods of price stagnation and call for leadership changes.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community rallies around its long-standing presence on the Solana network, with members actively promoting the ticker through high-engagement social campaigns and celebrating its status on major decentralized exchange swap lists. Discussions remain heavily focused on the coin's 'dad joke' meme origins and sustained community efforts, with users frequently coordinating social media posts to maintain visibility alongside other popular market assets.

The Bank of Nova Scotia engages in the provision of financial products and services including personal, commercial, corporate, and investment banking. It operates through the following segments: Canadian Banking, International Banking, Global Wealth Management, Global Banking and Markets, and Other. The company was founded on March 30, 1832 and is headquartered in Toronto, Canada.

Bank Of Nova Scotia

Bank of Nova Scotia is experiencing significant investor activity driven by its recent strategic equity investment in KeyCorp and a focus on expanding its North American footprint. Market participants are actively discussing the bank's valuation, potential growth catalysts, and dividend sustainability amid shifting interest rate expectations.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding Company is currently under intense scrutiny following a federal lawsuit against BNY Mellon and others, alleging a scheme that misappropriated DVLT shares as collateral to trigger forced liquidations. Investors are actively debating the potential for a massive supply shock if the court orders a share freeze, while simultaneously voicing significant frustration over the lack of transparency regarding financial reporting and the company's complex, interlinked strategic investments.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is surging in social sentiment following the announcement of a strategic partnership with FedEx, fueling community speculation about the impact of large-scale, enterprise-grade logistical integration on the network's long-term utility. While retail sentiment remains polarized between cautious accumulation and exhaustion from prolonged price consolidation, discussions are dominated by optimism surrounding the network's expanding governing council and its potential role in powering AI and autonomous infrastructure.

Neptune Insurance Holdings, Inc. engages in the provision of residential and commercial insurance products. It offers primary flood, excess flood, and parametric earthquake insurance. The company was founded by Trevor Burgess on February 10, 2017 and is headquartered in St. Petersburg, FL.

Neptune Insurance Holdings Inc. - Ordinary Shares- Class A

Neptune Insurance Holdings Inc.

Neptune Insurance Holdings is trending as investors digest its recent earnings report, a significant CEO stock purchase, and the company's expansion into digital flood insurance via ChatGPT. The community remains divided, with active discussions focusing on institutional growth potential, ongoing index exclusion concerns, and technical price support levels.

Axelar delivers secure interchain communication. That means dApp users can interact with any asset, any application, on any chain, with one click. You can think of it as Stripe for Web3. Developers interact with a simple API atop a permissionless network that routes messages and ensures network security via proof-of-stake consensus.  Axelar is a blockchain that connects blockchains. To do this securely, Axelar network uses proof-of-stake consensus. Network validators produce new blocks, participate in multiparty signing and vote on external chain states. Tokenholders stake the AXL token, delegating tokens to a validator’s staking pool and receiving rewards, minus the validator’s commission.  The AXL token is used for governance and to pay network transaction fees to validators and tokenholders. However, users of the Axelar network do not need to hold the token. Conversions into AXL tokens and destination-chain tokens are handled on the back end, so that users need only pay gas once, in the source-chain token.  Axelar network rewards are “inflationary” — they increase the total supply of AXL — but there is potential for supply to become deflationary based on the transaction fee mechanic described above.

Axelar

Axelar is drawing significant investor interest as the market closely monitors its role in cross-chain interoperability, specifically regarding its integration with major projects like the XRP Ledger and stablecoin infrastructure. Community sentiment remains polarized, with many users actively discussing the balance between long-term technological potential and short-term volatility following recent development updates and team transitions.

Telesat Corp. engages in the provision of satellite communications and consulting services. It operates through Geostationary (GEO) and Low Earth Orbit (LEO) segments. It is a global satellite operator, providing mission-critical communications solutions to support the requirements of sophisticated satellite users throughout the world and consists of 14 geostationary satellites and the Canadian payload on Viasat-1. The company was founded in 1969 and is headquartered in Ottawa, Canada.

Telesat Corp - Ordinary Shares - Class A

Telesat is generating significant market interest following the announcement of a multi-launch agreement with SpaceX to deploy its Lightspeed LEO satellite constellation, fueling community speculation about a major stock re-rating. Investors are closely monitoring the company's progress on government-backed funding and backlog expansion as they debate its potential to compete with industry incumbents.

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.

Keros Therapeutics Inc

Keros Therapeutics is seeing intense market activity following a significant price decline triggered by the voluntary halt of a Phase 2 trial for its pulmonary arterial hypertension candidate due to safety concerns. While the company maintains a robust cash position and ongoing pipeline development, the community remains divided between investors viewing the sell-off as a severe overreaction to a non-lead asset and those concerned about the company's long-term clinical execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

C4 Therapeutics Details MOMENTUM Phase 2 Start, Eyes Near-Term Decision on EGFR Program at Barclays Confab

C4 Therapeutics (NASDAQ:CCCC) outlined near-term clinical plans for its targeted protein degradation pipeline during a presentation at Barclays' 28th Annual Global Healthcare Conference, highlighting...

C4 Therapeutics Maps Accelerated Approval Path for Myeloma Drug Cemsidomide at TD Cowen Conference

C4 Therapeutics (NASDAQ:CCCC) used a presentation at TD Cowen's 46th Annual Healthcare Conference to outline its near- and mid-term clinical plans, emphasizing its lead multiple myeloma program...

Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice

Does C4 Therapeutics, Inc. (CCCC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?

Here is how BrightSpring Health Services, Inc. (BTSG) and C4 Therapeutics, Inc. (CCCC) have performed compared to their sector so far this year.

Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types

Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types PR Newswire VANCOUVER...

C4 Therapeutics (NASDAQ:CCCC) Upgraded to Hold at Wall Street Zen

Wall Street Zen raised shares of C4 Therapeutics from a "strong sell" rating to a "hold" rating in a research note on Saturday...

C4 Therapeutics (NASDAQ:CCCC) Issues Earnings Results, Beats Expectations By $0.25 EPS

C4 Therapeutics (NASDAQ:CCCC - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.18) EPS for the quarter, topping analysts' consensus estimates of ($0.43) by...

C4 Therapeutics, Inc. (NASDAQ:CCCC) Given Average Recommendation of "Moderate Buy" by Brokerages

C4 Therapeutics, Inc. (NASDAQ:CCCC - Get Free Report) has received an average rating of "Moderate Buy" from the eight ratings firms that are covering the company, MarketBeat Ratings reports. One...

C4 Therapeutics (NASDAQ:CCCC) Stock Price Expected to Rise, Brookline Capital Acquisition Analyst Says

Brookline Capital Acquisition raised their price target on C4 Therapeutics from $20.00 to $30.00 and gave the stock a "buy" rating in a research note on Monday...

C4 Therapeutics (CCCC) Projected to Post Quarterly Earnings on Thursday

C4 Therapeutics (NASDAQ:CCCC) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Watertown, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.27	--	--	N/A
Q4 '25	-$0.30	-$0.18	39.02%	BEAT
Q3 '25	-$0.41	-$0.44	-8.45%	MISSED
Q2 '25	-$0.38	-$0.37	3.65%	BEAT
Q1 '25	-$0.44	-$0.37	16.29%	BEAT

CCCC
C4 Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest CCCC News

CCCCC4 Therapeutics Inc